Free Trial

Surmodics (SRDX) Competitors

Surmodics logo
$27.39 -0.11 (-0.40%)
As of 01:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SRDX vs. IART, OFIX, ANGO, ARAY, RMTI, ABT, ISRG, BSX, SYK, and MDT

Should you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include Integra LifeSciences (IART), Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

Surmodics vs. Its Competitors

Surmodics (NASDAQ:SRDX) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

96.6% of Surmodics shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 8.9% of Surmodics shares are owned by insiders. Comparatively, 3.5% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Surmodics currently has a consensus target price of $43.00, indicating a potential upside of 56.99%. Integra LifeSciences has a consensus target price of $16.17, indicating a potential upside of 0.26%. Given Surmodics' stronger consensus rating and higher possible upside, research analysts plainly believe Surmodics is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surmodics
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Integra LifeSciences
4 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.75

Integra LifeSciences has higher revenue and earnings than Surmodics. Surmodics is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surmodics$126.08M3.11-$11.54M-$1.23-22.27
Integra LifeSciences$1.61B0.78-$6.94M-$6.53-2.47

Surmodics has a net margin of -14.59% compared to Integra LifeSciences' net margin of -30.87%. Integra LifeSciences' return on equity of 12.15% beat Surmodics' return on equity.

Company Net Margins Return on Equity Return on Assets
Surmodics-14.59% -2.99% -1.99%
Integra LifeSciences -30.87%12.15%4.32%

Surmodics has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.

In the previous week, Integra LifeSciences had 2 more articles in the media than Surmodics. MarketBeat recorded 2 mentions for Integra LifeSciences and 0 mentions for Surmodics. Integra LifeSciences' average media sentiment score of 0.20 beat Surmodics' score of 0.00 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company Overall Sentiment
Surmodics Neutral
Integra LifeSciences Neutral

Summary

Surmodics and Integra LifeSciences tied by winning 8 of the 16 factors compared between the two stocks.

Get Surmodics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRDX vs. The Competition

MetricSurmodicsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$391.18M$10.74B$6.17B$10.79B
Dividend YieldN/A1.87%5.72%4.83%
P/E Ratio-22.2421.2429.8628.66
Price / Sales3.1131.36502.16190.02
Price / Cash91.4124.6936.5560.64
Price / Book3.293.4812.046.62
Net Income-$11.54M$210.63M$3.33B$276.93M
7 Day Performance-2.14%0.40%1.59%2.04%
1 Month Performance-10.08%0.20%6.23%2.66%
1 Year Performance-28.17%-7.69%61.20%33.98%

Surmodics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRDX
Surmodics
3.6453 of 5 stars
$27.39
-0.4%
$43.00
+57.0%
-28.2%$391.18M$126.08M-22.24450
IART
Integra LifeSciences
2.5646 of 5 stars
$13.62
+2.1%
$16.83
+23.6%
-16.9%$1.04B$1.61B-2.094,396Upcoming Earnings
OFIX
Orthofix Medical
2.3757 of 5 stars
$14.50
+2.1%
$21.75
+50.0%
+1.6%$560.82M$799.49M-4.571,616News Coverage
Analyst Forecast
ANGO
AngioDynamics
4.4976 of 5 stars
$11.13
+1.2%
$19.33
+73.7%
+68.1%$453.20M$292.50M-14.27760Positive News
Analyst Forecast
Insider Trade
ARAY
Accuray
4.221 of 5 stars
$1.76
-0.6%
$5.00
+184.1%
-9.1%$199.51M$458.51M-88.001,040Analyst Forecast
Gap Up
RMTI
Rockwell Medical
3.692 of 5 stars
$1.14
+3.6%
$4.00
+250.9%
-67.0%$37.87M$101.49M-19.00300
ABT
Abbott Laboratories
4.9793 of 5 stars
$131.52
-0.8%
$146.17
+11.1%
+8.1%$230.73B$41.95B16.48114,000Positive News
Analyst Forecast
ISRG
Intuitive Surgical
4.6095 of 5 stars
$435.73
+1.4%
$584.76
+34.2%
+7.6%$154.00B$8.35B60.7715,638Trending News
Earnings Report
Analyst Forecast
Options Volume
BSX
Boston Scientific
4.7951 of 5 stars
$94.92
-0.5%
$120.71
+27.2%
+17.1%$141.37B$16.75B56.5053,000Trending News
Earnings Report
Analyst Forecast
Options Volume
Analyst Revision
SYK
Stryker
4.8319 of 5 stars
$364.95
+0.1%
$432.14
+18.4%
+5.6%$139.39B$22.60B48.3453,000Positive News
Upcoming Earnings
Analyst Forecast
MDT
Medtronic
4.95 of 5 stars
$95.63
+0.2%
$102.41
+7.1%
+2.1%$122.43B$33.54B26.3495,000Positive News
Options Volume

Related Companies and Tools


This page (NASDAQ:SRDX) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners